Is CDKN2A p.Pro114Leu (c.341C>T) pathogenic?

CDKN2A p.Pro114Leu (c.341C>T) is classified Conflicting classifications of pathogenicity in CDKN2A (ClinVar, Conflicting submitters, 4 submitters; last evaluated 2024-07-22). AlphaMissense: likely pathogenic (0.8805); Absent from gnomAD v4.1; Associated with hereditary neoplastic syndrome.

What condition is associated with CDKN2A p.Pro114Leu (c.341C>T)?

CDKN2A p.Pro114Leu (c.341C>T) is associated with hereditary neoplastic syndrome, urinary bladder cancer, familial melanoma (ClinVar).

How common is CDKN2A p.Pro114Leu (c.341C>T) in the general population?

CDKN2A p.Pro114Leu (c.341C>T) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about CDKN2A p.Pro114Leu (c.341C>T)?

AlphaMissense predicts likely pathogenic (score 0.8805) — an in-silico prediction, not a clinical call.

CDKN2A p.Pro114Leu

c.341C>T · rs121913386 · VCV77637

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 4 submitters

AlphaMissense

likely pathogenic

0.8805 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

3/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.8805	likely pathogenic
REVEL	0.872	moderately pathogenic-leaning
SaProt	LLR -13.96	damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 12	GERP 2, phastCons 1
Regional constraint	o/e 1.13	unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic
Overall
CADD	29.5	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: CDKN2A
Protein: p.Pro114Leu
Coding: c.341C>T
MANE Select: NM_000077
dbSNP: rs121913386
Type: single nucleotide variant
Location: chr9:21971018 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 114: an α-helix; a UniProt-annotated variant site (in non-small cell lung carcinoma); a UniProt-annotated variant site (found in some patients with melanoma; loss of cdk4 binding); the 'disordered' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: urinary bladder cancer familial melanoma

Similar variants

CDKN2A p.Pro114Arg Likely pathogenic ★ same residue
CDKN2A p.Pro114= Conflicting classifications of pathogenicity ★ same residue
CDKN2A p.Pro114Ser Uncertain significance ★ ⚠ same residue
CDKN2A p.Pro114Thr Uncertain significance ★ ⚠ same residue
CDKN2A p.Pro114fs Pathogenic/Likely pathogenic ★★ same residue
CDKN2A c.150+1G>A Likely pathogenic ★★ same condition
CDKN2A c.150+2T>G Likely pathogenic ★★ same condition
CDKN2A c.151-1G>A Pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-pro114leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown